Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	MYO1G ATP6V1A ERCC3 ABCF3 MYO9A SMC6 MCM5 MYO1B IDE RFC1 DNAH7 BPTF TRAP1 KIF14 DDX23 MACF1 ATP6V0D2 DNAH6 DYNC1I1 SLC27A2	5.21e-07	614	176	20	GO:0140657
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYO1G MYO9A MYO1B DNAH7 KIF14 DNAH6 DYNC1I1	8.50e-05	118	176	7	GO:0003774
GeneOntologyMolecularFunction	gamma-catenin binding	APC PTPRJ CTNNA1	1.40e-04	12	176	3	GO:0045295
GeneOntologyMolecularFunction	ATP hydrolysis activity	ATP6V1A ERCC3 ABCF3 SMC6 MCM5 IDE RFC1 DNAH7 TRAP1 KIF14 DDX23 MACF1 DNAH6	1.52e-04	441	176	13	GO:0016887
GeneOntologyMolecularFunction	glycosyltransferase activity	GALNT14 PIGB B3GLCT PARP2 COLGALT2 STT3A GXYLT2 ALG14 PYGM FUT6	2.47e-04	288	176	10	GO:0016757
GeneOntologyCellularComponent	cell leading edge	MYO1G MYLK APC HCN2 ACTR3 PLEK2 MTMR6 PTPRJ MACF1 CTNNA1 DAGLA PHLDB2 CDK6	2.80e-04	500	173	13	GO:0031252
GeneOntologyCellularComponent	leading edge membrane	MYO1G APC HCN2 PLEK2 MTMR6 PTPRJ MACF1 DAGLA	3.72e-04	210	173	8	GO:0031256
GeneOntologyCellularComponent	adherens junction	APC FAT2 TJP1 DLG4 LRRC7 CTNNA1 PLEKHA7 SMAD7	3.97e-04	212	173	8	GO:0005912
GeneOntologyCellularComponent	cell-cell junction	NRAP MYLK APC TENM2 ACTR3 FAT2 PTPRJ TJP1 DLG4 LRRC7 CTNNA1 FLRT3 PLEKHA7 SMAD7	4.18e-04	591	173	14	GO:0005911
MousePheno	abnormal head morphology	ALX3 DOCK1 NCOA3 IFT140 ITGA11 B3GLCT ACD IFT172 KAT6A ESRP1 APC FBXO11 IDE RAX TGIF1 EHBP1L1 GTF2I PTPRJ NFE2L2 MITF ANKRD11 KIF14 TBX10 GNA11 PAX7 KAT6B TBX1 SMAD7 SORL1	2.24e-06	1120	142	29	MP:0000432
MousePheno	abnormal axial skeleton morphology	DOCK1 NCOA3 TPTE IFT140 ITGA11 B3GLCT TRIM61 MYO9A SPEF2 KAT6A ESRP1 APC FBXO11 IDE PLEKHM1 PLEK2 HOXA6 TGIF1 BPTF EHBP1L1 NFE2L2 AASS P3H1 MITF ANKRD11 TBX10 GNA11 PRMT3 PAX7 MAPK6 KAT6B TBX1	1.95e-05	1458	142	32	MP:0002114
MousePheno	short face	B3GLCT FBXO11 TGIF1 ANKRD11	2.19e-05	17	142	4	MP:0030066
MousePheno	abnormal craniofacial development	ALX3 IFT140 ITGA11 B3GLCT IFT172 KAT6A ESRP1 RAX GTF2I NFE2L2 MITF TBX10 PAX7 TBX1 SMAD7	2.75e-05	425	142	15	MP:0003935
MousePheno	abnormal facial morphology	ALX3 DOCK1 NCOA3 IFT140 ITGA11 B3GLCT IFT172 KAT6A ESRP1 FBXO11 IDE RAX TGIF1 EHBP1L1 GTF2I NFE2L2 MITF ANKRD11 TBX10 PAX7 TBX1 SMAD7 SORL1	4.33e-05	910	142	23	MP:0003743
MousePheno	abnormal craniofacial morphology	ALX3 DOCK1 NCOA3 IFT140 ITGA11 B3GLCT ACD IFT172 SPEF2 KAT6A ESRP1 APC FBXO11 IDE RAX TGIF1 EHBP1L1 GTF2I NFE2L2 MITF ANKRD11 KIF14 TBX10 GNA11 PAX7 KAT6B TBX1 SMAD7 SORL1	1.03e-04	1372	142	29	MP:0000428
MousePheno	craniofacial phenotype	ALX3 DOCK1 NCOA3 IFT140 ITGA11 B3GLCT ACD IFT172 SPEF2 KAT6A ESRP1 APC FBXO11 IDE RAX TGIF1 EHBP1L1 GTF2I NFE2L2 MITF ANKRD11 KIF14 TBX10 GNA11 PAX7 KAT6B TBX1 SMAD7 SORL1	1.03e-04	1372	142	29	MP:0005382
MousePheno	abnormal viscerocranium morphology	DOCK1 NCOA3 IFT140 ITGA11 B3GLCT KAT6A ESRP1 APC IDE TGIF1 EHBP1L1 NFE2L2 MITF ANKRD11 PAX7 KAT6B TBX1	1.07e-04	593	142	17	MP:0005274
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	ATP6V1A ERCC3 MCM5 NUP58 ACTR3B ACTR3 EFR3A TJP1 P3H1 USP7 KIF14 DDX23 MACF1 GNA11 CDC5L PHLDB2 NOS1AP CDK6	9.99e-09	660	178	18	32780723
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	MARS2 ATP6V1A PCLO UBR4 TM9SF3 SMC6 NIPSNAP1 THUMPD3 MCM5 MYO1B IDE XPO1 RFC1 ACTR3 STT3A TRAP1 GTF2I NT5DC2 EIF3L KLHL23 USP7 KIF14 LTV1 PRMT3 CDC5L PLEKHA7	1.99e-08	1425	178	26	30948266
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DOCK1 ATP6V1A SLC25A42 MYO9A TTC21A KAT6A PON2 IDE PLEKHM1 STT3A ZNF462 BPTF TLK1 GTF2I PTPRJ TJP1 TBC1D22A KLHL23 ANKRD11 MACF1 LRRC7 DCLK2 MAPK6 KAT6B DAGLA	1.86e-07	1489	178	25	28611215
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	USP34 UBR4 MCM5 MYO1B XPO1 RFC1 ACTR3 BPTF GTF2I TJP1 EIF3L USP7 KIF14 DDX23 MACF1 CTNNA1	2.90e-07	653	178	16	22586326
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	USP34 ATP6V1A PARP2 UBR4 TM9SF3 AGPAT4 PON2 MCM5 MYO1B XPO1 RFC1 ACTR3 STT3A TRAP1 GTF2I AASS EIF3L USP7 ASCC2 KIF14 DDX23 CTNNA1 CDC5L SLC27A2	3.83e-07	1440	178	24	30833792
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	ERCC3 ABCF3 MYO9A UBR4 NIPSNAP1 THUMPD3 NEK7 RIOK3 MCM5 MYO1B XPO1 RFC1 ACTR3 PLEK2 GTF2I EIF3L USP7 DDX23 MACF1 LTV1 PRMT3 CDC5L PHLDB2	4.88e-07	1353	178	23	29467282
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ATP6V1A MYO9A TTC21A PCLO NIPSNAP1 APC XPO1 ACTR3B ACTR3 TJP1 EIF3L USP7 MACF1 DLG4 LRRC7 DCLK2 CTNNA1 CDC5L PLEKHA7 DNAH6 DAGLA UNC13A DYNC1I1	1.27e-06	1431	178	23	37142655
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	USP34 TPTE MYO9A SYT17 SLCO3A1 DNAH7 BPTF MTMR6 AATK P3H1 SLC45A2 PLEKHA7	1.96e-06	420	178	12	28065597
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	USP34 NCOA3 MCM5 XPO1 ZNF462 GTF2I USP7 DDX23 CDC5L	2.20e-06	220	178	9	35785414
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	DOCK1 TPTE AFF2 UBR4 CCDC141 AATK NFE2L2 MITF USP7 PAX7 CAMSAP1 PLEKHA7	2.50e-06	430	178	12	35044719
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	USP34 TPTE IFT172 UBR4 TM9SF3 PON2 MCM5 IDE XPO1 STT3A MTMR6 GTF2I TJP1 NT5DC2 DLG4 CTNNA1 CDC5L SORL1	2.97e-06	974	178	18	28675297
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	MYO1B RFC1 FAT2 GTF2I USP7 MACF1 LTV1 CDC5L CAMSAP1	3.64e-06	234	178	9	36243803
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	NCOA3 UBR4 TM9SF3 PON2 COLGALT2 IDE RFC1 CSMD2 DNAH7 EHBP1L1 AASS LTV1 TIGD5 CSPP1	5.86e-06	638	178	14	31182584
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	GALNT14 TPTE MYLK RPS6KA5 KAT6A APC RIOK3 CPN1 STT3A TLK1 MTMR6 PRMT3 MAPK6 KAT6B CDK6	5.93e-06	730	178	15	34857952
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	ATP6V1A ERCC3 C9orf78 PON2 MYO1B XPO1 RFC1 TRAP1 GTF2I NT5DC2 ASCC2 DDX23 PRMT3	7.01e-06	560	178	13	35241646
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	ERCC3 PARP2 TM9SF3 MCM5 MYO1B XPO1 RFC1 ACTR3 STT3A PLEK2 GTF2I TJP1 EIF3L USP7 ASCC2 KIF14 LTV1 CTNNA1 CDC5L PHLDB2	7.66e-06	1257	178	20	36526897
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	UBR4 NIPSNAP1 NEK7 PON2 RIOK3 MCM5 MYO1B ACTR3B ACTR3 CDAN1 TGIF1 TLK1 GTF2I EIF3L USP7 DDX23 PYGM LRRC7 CDC5L CDK6	1.04e-05	1284	178	20	17353931
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	MARS2 PCLO UBR4 MCM5 MYO1B XPO1 STT3A TJP1 NT5DC2 MACF1 CTNNA1 CDK6	1.10e-05	498	178	12	36634849
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	NCOA3 IFT140 IFT172 TTC21A TM9SF3 SMC6 NIPSNAP1 NEK7 ACTR3 TLK1 TRAP1 GTF2I EIF3L LTV1 CTNNA1 PLEKHA7 CSPP1 RSPH10B PHLDB2 SORL1	1.57e-05	1321	178	20	27173435
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	USP34 ATP6V1A ABCF3 C9orf78 UBR4 THUMPD3 MCM5 IDE XPO1 ACTR3 CDAN1 TRAP1 EHBP1L1 GTF2I P3H1 EIF3L USP7 MACF1 LTV1 PRMT3 CTNNA1	1.93e-05	1455	178	21	22863883
Pubmed	Proteomic and Interactome Approaches Reveal PAK4, PHB-2, and 14-3-3η as Targets of Overactivated Cdc42 in Cellular Responses to Genomic Instability.	ATP6V1A PDE6C XPO1 ACTR3 P3H1 NQO1 CTNNA1 CDC5L	2.25e-05	225	178	8	31478661
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	USP34 ZNF462 TLK1 AATK MACF1 CDC5L KAT6B DAGLA	2.25e-05	225	178	8	12168954
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	ATP6V1A PCLO UBR4 NIPSNAP1 APC DGKG ACTR3B TENM2 TRAP1 TJP1 USP7 MACF1 DLG4 LRRC7 DCLK2 CAMSAP1 UNC13A NOS1AP	2.45e-05	1139	178	18	36417873
Pubmed	Control of cellular redox status and upregulation of quinone reductase NQO1 via Nrf2 activation by alpha-lipoic acid in human leukemia HL-60 cells.	NFE2L2 NQO1	2.60e-05	2	178	2	18813798
Pubmed	Dual-negative expression of Nrf2 and NQO1 predicts superior outcomes in patients with non-small cell lung cancer.	NFE2L2 NQO1	2.60e-05	2	178	2	28501854
Pubmed	Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to β-lapachone.	NFE2L2 NQO1	2.60e-05	2	178	2	32007910
Pubmed	MLCK-dependent exchange and actin binding region-dependent anchoring of ZO-1 regulate tight junction barrier function.	MYLK TJP1	2.60e-05	2	178	2	20404178
Pubmed	Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate experimental non-alcoholic steatohepatitis via Nrf2/NQO-1 pathway.	NFE2L2 NQO1	2.60e-05	2	178	2	36096356
Pubmed	Proteomic identification of overexpressed adenomatous polyposis coli and cyclin B3 during endoderm differentiation from human embryonic stem cells.	APC CCNB3	2.60e-05	2	178	2	21404461
Pubmed	Identification of a novel nuclear localization signal in Tbx1 that is deleted in DiGeorge syndrome patients harboring the 1223delC mutation.	TBX10 TBX1	2.60e-05	2	178	2	15703190
Pubmed	Bridging of nucleosome-proximal DNA double-strand breaks by PARP2 enhances its interaction with HPF1.	PARP2 HPF1	2.60e-05	2	178	2	33141820
Pubmed	Docosahexanoic acid signals through the Nrf2-Nqo1 pathway to maintain redox balance and promote neurite outgrowth.	NFE2L2 NQO1	2.60e-05	2	178	2	33502893
Pubmed	APC is required for muscle stem cell proliferation and skeletal muscle tissue repair.	APC PAX7	2.60e-05	2	178	2	26304725
Pubmed	Luteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the Nrf2 pathway.	NFE2L2 NQO1	2.60e-05	2	178	2	24761924
Pubmed	ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion.	NCOA3 MAPK6	2.60e-05	2	178	2	22505454
Pubmed	Association of Genetic Variations in NRF2, NQO1, HMOX1, and MT with Severity of Coronary Artery Disease and Related Risk Factors.	NFE2L2 NQO1	2.60e-05	2	178	2	31332605
Pubmed	ERα status of invasive ductal breast carcinoma as a result of regulatory interactions between lysine deacetylases KAT6A and KAT6B.	KAT6A KAT6B	2.60e-05	2	178	2	39505971
Pubmed	Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma.	NFE2L2 NQO1	2.60e-05	2	178	2	31968140
Pubmed	Inflammation, oxidative stress, and higher expression levels of Nrf2 and NQO1 proteins in the airways of women chronically exposed to biomass fuel smoke.	NFE2L2 NQO1	2.60e-05	2	178	2	29363060
Pubmed	The double PHD finger domain of MOZ/MYST3 induces α-helical structure of the histone H3 tail to facilitate acetylation and methylation sampling and modification.	KAT6A KAT6B	2.60e-05	2	178	2	24150941
Pubmed	Activation of Akt and JNK/Nrf2/NQO1 pathway contributes to the protective effect of coptisine against AAPH-induced oxidative stress.	NFE2L2 NQO1	2.60e-05	2	178	2	27903425
Pubmed	Liver expression of Nrf2-related genes in different liver diseases.	NFE2L2 NQO1	2.60e-05	2	178	2	26459724
Pubmed	Nrf2-dependent induction of NQO1 in mouse aortic endothelial cells overexpressing catalase.	NFE2L2 NQO1	2.60e-05	2	178	2	21569840
Pubmed	Mesenchymal MACF1 Facilitates SMAD7 Nuclear Translocation to Drive Bone Formation.	MACF1 SMAD7	2.60e-05	2	178	2	32143362
Pubmed	NQO1 and NFE2L2 polymorphisms, fruit and vegetable intake and smoking and the risk of colorectal adenomas in an endoscopy-based population.	NFE2L2 NQO1	2.60e-05	2	178	2	18074351
Pubmed	The influence of fruit and vegetable consumption and genetic variation on NAD(P)H:quinone oxidoreductase (NQO1) phenotype in an endoscopy-based population.	NFE2L2 NQO1	2.60e-05	2	178	2	18444152
Pubmed	Nuclear factor-E2-related factor 2 expression in liver is critical for induction of NAD(P)H:quinone oxidoreductase 1 during cholestasis.	NFE2L2 NQO1	2.60e-05	2	178	2	17278884
Pubmed	ARP3beta, the gene encoding a new human actin-related protein, is alternatively spliced and predominantly expressed in brain neuronal cells.	ACTR3B ACTR3	2.60e-05	2	178	2	10806390
Pubmed	Laminar flow induction of antioxidant response element-mediated genes in endothelial cells. A novel anti-inflammatory mechanism.	NFE2L2 NQO1	2.60e-05	2	178	2	12370194
Pubmed	ESRP1 controls biogenesis and function of a large abundant multiexon circRNA.	DOCK1 ESRP1	2.60e-05	2	178	2	38015468
Pubmed	Bridging of DNA breaks activates PARP2-HPF1 to modify chromatin.	PARP2 HPF1	2.60e-05	2	178	2	32939087
Pubmed	Regulation of KAT6 Acetyltransferases and Their Roles in Cell Cycle Progression, Stem Cell Maintenance, and Human Disease.	KAT6A KAT6B	2.60e-05	2	178	2	27185879
Pubmed	Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression.	NCOA3 ANKRD11	2.60e-05	2	178	2	31788936
Pubmed	USP7 inactivation suppresses APC-mutant intestinal hyperproliferation and tumor development.	APC USP7	2.60e-05	2	178	2	36669491
Pubmed	BPTF transduces MITF-driven prosurvival signals in melanoma cells.	BPTF MITF	2.60e-05	2	178	2	27185926
Pubmed	Association between 18F-FDG uptake in PET/CT, Nrf2, and NQO1 expression and their prognostic significance in non-small cell lung cancer.	NFE2L2 NQO1	2.60e-05	2	178	2	30868898
Pubmed	Site-directed mutagenesis of cysteine to serine in the DNA binding region of Nrf2 decreases its capacity to upregulate antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene.	NFE2L2 NQO1	2.60e-05	2	178	2	11948402
Pubmed	Leads from xenobiotic metabolism genes for Parkinson's disease among north Indians.	PON2 NQO1	2.60e-05	2	178	2	22016051
Pubmed	MITF protects against oxidative damage-induced retinal degeneration by regulating the NRF2 pathway in the retinal pigment epithelium.	NFE2L2 MITF	2.60e-05	2	178	2	32361183
Pubmed	Differentiation-dependent expression of NADP(H):quinone oxidoreductase-1 via NF-E2 related factor-2 activation in human epidermal keratinocytes.	NFE2L2 NQO1	2.60e-05	2	178	2	21524888
Pubmed	NCOA3, a new fusion partner for MOZ/MYST3 in M5 acute myeloid leukemia.	NCOA3 KAT6A	2.60e-05	2	178	2	17805331
Pubmed	Mitochondrial NADP(H) deficiency due to a mutation in NADK2 causes dienoyl-CoA reductase deficiency with hyperlysinemia.	NADK2 AASS	2.60e-05	2	178	2	24847004
Pubmed	Nitric oxide-induced transcriptional up-regulation of protective genes by Nrf2 via the antioxidant response element counteracts apoptosis of neuroblastoma cells.	NFE2L2 NQO1	2.60e-05	2	178	2	14985350
Pubmed	Chromatin-Remodelling Complex NURF Is Essential for Differentiation of Adult Melanocyte Stem Cells.	BPTF MITF	2.60e-05	2	178	2	26440048
Pubmed	Metabolic targeting of NRF2 potentiates the efficacy of the TRAP1 inhibitor G-TPP through reduction of ROS detoxification in colorectal cancer.	TRAP1 NFE2L2	2.60e-05	2	178	2	36113636
Pubmed	Activation of PARP2/ARTD2 by DNA damage induces conformational changes relieving enzyme autoinhibition.	PARP2 HPF1	2.60e-05	2	178	2	34108479
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	C9orf78 SMC6 APC IDE XPO1 ACTR3 TLK1 TRAP1 GTF2I TJP1 P3H1 EIF3L KIF14 DDX23 PYGM LTV1 CTNNA1 CDC5L	2.94e-05	1155	178	18	20360068
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	TPTE MYO1B IDE XPO1 ACTR3 EFR3A MTMR6 PTPRJ TJP1 P3H1 USP7 KIF14 CTNNA1 CDC5L PLEKHA7 CSPP1 NOS1AP	3.04e-05	1049	178	17	27880917
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	MARS2 ATP6V1A NADK2 UBR4 NIPSNAP1 THUMPD3 APC PON2 MYO1B XPO1 RFC1 STT3A BPTF MTMR6 TJP1 P3H1 EIF3L MACF1 CDK6	4.05e-05	1297	178	19	33545068
Pubmed	The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.	USP34 PCLO UBR4 FBXO11 CDAN1 BPTF P3H1 NT5DC2 USP7 CDC5L	4.09e-05	396	178	10	26687479
Pubmed	Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.	ATP6V1A UBR4 MCM5 MYO1B XPO1 ACTR3 USP7 CTNNA1 CDC5L CDK6	4.35e-05	399	178	10	37536630
Pubmed	A human MAP kinase interactome.	DOCK1 IFT140 ZBTB8OS RPS6KA5 MYO9A APC NUP58 TLK1 MACF1 CTNNA1 MAPK6	4.55e-05	486	178	11	20936779
Pubmed	Nf2 fine-tunes proliferation and tissue alignment during closure of the optic fissure in the embryonic mouse eye.	TJP1 MITF CTNNA1	4.60e-05	14	178	3	33075808
Pubmed	USP7 Is a Tumor-Specific WNT Activator for APC-Mutated Colorectal Cancer by Mediating β-Catenin Deubiquitination.	APC USP7 CTNNA1	7.03e-05	16	178	3	29045831
Pubmed	Spatial and temporal regulation of Wnt/beta-catenin signaling is essential for development of the retinal pigment epithelium.	RAX MITF CTNNA1	7.03e-05	16	178	3	19596317
Pubmed	Dlg3 trafficking and apical tight junction formation is regulated by nedd4 and nedd4-2 e3 ubiquitin ligases.	TJP1 DLG4 DYNC1I1	7.03e-05	16	178	3	21920314
Pubmed	A directed protein interaction network for investigating intracellular signal transduction.	ATP6V1A IFT140 RPS6KA5 C9orf78 UBR4 NIPSNAP1 MCM5 NUP58 RFC1 PLEKHM1 TGIF1 BPTF EIF3L KLHL23 CTNNA1 MAPK6 DYNC1I1	7.13e-05	1124	178	17	21900206
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	USP34 NCOA3 ATP6V1A ERCC3 UBR4 SMC6 MCM5 XPO1 RFC1 BPTF GTF2I EIF3L NQO1 USP7 DDX23 CDC5L	7.18e-05	1014	178	16	32416067
Pubmed	Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.	TENM2 TJP1 MACF1 PYGM DLG4 LRRC7 CAMSAP1	7.41e-05	197	178	7	36604605
Pubmed	Replication of previous genome-wide association studies of bone mineral density in premenopausal American women.	RPS6KA5 DGKG CPN1 SMAD7	7.67e-05	44	178	4	20200978
Pubmed	Modulation of Nrf2/Keap1 system by Wasabi 6-methylthiohexyl isothiocyanate in ARE-mediated NQO1 expression.	NFE2L2 NQO1	7.79e-05	3	178	2	23390006
Pubmed	Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.	NFE2L2 SMAD7	7.79e-05	3	178	2	31059771
Pubmed	Exclusion of mutations in TGIF, ALX3, and ALX4 genes in patients with the syndrome of frontonasal dysgenesis, callosal agenesis, basal encephalocele, and eye anomalies.	ALX3 TGIF1	7.79e-05	3	178	2	22496059
Pubmed	A role for ZO-1 and PLEKHA7 in recruiting paracingulin to tight and adherens junctions of epithelial cells.	TJP1 PLEKHA7	7.79e-05	3	178	2	21454477
Pubmed	HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation.	PARP2 HPF1	7.79e-05	3	178	2	32028527
Pubmed	HIV-1 gp120 induces antioxidant response element-mediated expression in primary astrocytes: role in HIV associated neurocognitive disorder.	NFE2L2 NQO1	7.79e-05	3	178	2	21756955
Pubmed	Serine-linked PARP1 auto-modification controls PARP inhibitor response.	PARP2 HPF1	7.79e-05	3	178	2	34210965
Pubmed	Regulation of HER2 oncogene transcription by a multifunctional coactivator/corepressor complex.	NCOA3 ANKRD11	7.79e-05	3	178	2	24678732
Pubmed	Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants.	NFE2L2 NQO1	7.79e-05	3	178	2	15734732
Pubmed	Lipopolysaccharide-induced expression of NAD(P)H:quinone oxidoreductase 1 and heme oxygenase-1 protects against excessive inflammatory responses in human monocytes.	NFE2L2 NQO1	7.79e-05	3	178	2	18981090
Pubmed	Association of the APC tumor suppressor protein with catenins.	APC CTNNA1	7.79e-05	3	178	2	8259519
Pubmed	[Effects of inorganic arsenic on mRNA expression of Nrf2 and Nrf2-regulated downstream anti-oxidant enzymes in Chang hepatocytes].	NFE2L2 NQO1	7.79e-05	3	178	2	21861350
Pubmed	[Effect of lipoxin A(4) on lipopolysaccharide-induced oxidant stress in human umbilical vein endothelial cells].	NFE2L2 NQO1	7.79e-05	3	178	2	21211285
Pubmed	Protease-activated receptor-2 activates NQO-1 via Nrf2 stabilization in keratinocytes.	NFE2L2 NQO1	7.79e-05	3	178	2	24326025
Pubmed	Methane Alleviates Acetaminophen-Induced Liver Injury by Inhibiting Inflammation, Oxidative Stress, Endoplasmic Reticulum Stress, and Apoptosis through the Nrf2/HO-1/NQO1 Signaling Pathway.	NFE2L2 NQO1	7.79e-05	3	178	2	31781345
Pubmed	Densin-180, a synaptic protein, links to PSD-95 through its direct interaction with MAGUIN-1.	DLG4 LRRC7	7.79e-05	3	178	2	12390249
Pubmed	Nrf2 activation does not affect adenoma development in a mouse model of colorectal cancer.	APC NFE2L2	7.79e-05	3	178	2	34526660
Pubmed	The colorectal tumour suppressor APC is present in the NMDA-receptor-PSD-95 complex in the brain.	APC DLG4	7.79e-05	3	178	2	11029657
Pubmed	Localisation of the gene encoding diacylglycerol kinase 3 (DAGK3) to human chromosome 3q27-28 and mouse chromosome 16.	DGKG TBX1	7.79e-05	3	178	2	8585934
Pubmed	APC regulation of ESRP1 and p120-catenin isoforms in colorectal cancer cells.	ESRP1 APC	7.79e-05	3	178	2	33237836
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	NCOA3 KAT6A KAT6B	2.40e-04	17	132	3	486
GeneFamily	PRD class homeoboxes and pseudogenes	ALX3 VSX1 RAX2 RAX PAX7	5.69e-04	92	132	5	521
GeneFamily	Intraflagellar transport proteins\|Tetratricopeptide repeat domain containing	IFT140 IFT172 TTC21A	6.88e-04	24	132	3	615
GeneFamily	Ubiquitin protein ligase E3 component n-recognins	UBR4 FBXO11	1.08e-03	7	132	2	785
GeneFamily	Myosins, class I	MYO1G MYO1B	1.44e-03	8	132	2	1097
GeneFamily	BEN domain containing	BEND2 BEND7	1.84e-03	9	132	2	422
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	DOCK1 USP34 NCOA3 KAT6A NEK7 APC ARFGEF1 MYO1B XPO1 MBOAT2 SNX13 EFR3A TGIF1 BPTF TLK1 MITF USP7 KIF14 MACF1 PRMT3 MAPK6 KAT6B SMAD7	1.87e-08	856	177	23	M4500
Coexpression	SHEN_SMARCA2_TARGETS_UP	ERCC3 NEK7 APC PON2 RIOK3 FBXO11 IDE XPO1 ACTR3 TLK1 MACF1 CTNNA1 CAMSAP1 REV1	1.43e-06	429	177	14	M29
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	MYO9A SMC6 THUMPD3 APC ARFGEF1 XPO1 RFC1 SNX13 BPTF MITF KIF14 SLC45A2 CDC5L MAPK6 CSPP1 DYNC1I1 SORL1	2.46e-06	656	177	17	M18979
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	NCOA3 KAT6A XPO1 BPTF TLK1 MTMR6 FAT2 NFE2L2 KIF14 KAT6B SMAD7	6.67e-06	300	177	11	M8702
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	NCOA3 KAT6A NEK7 ARFGEF1 MYO1B XPO1 SNX13 BPTF TLK1 KIF14 PRMT3 MAPK6 KAT6B	1.83e-05	466	177	13	M13522
Coexpression	ENK_UV_RESPONSE_KERATINOCYTE_DN	NCOA3 ATP6V1A KAT6A ARFGEF1 XPO1 ACTR3 STT3A BPTF FAT2 USP7 MACF1 CTNNA1 SORL1	2.55e-05	481	177	13	M3898
Coexpression	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN	GALNT14 NRAP MYO9A OLFML2B TM9SF3 KAT6A AGPAT4 SLCO3A1 DGKG CPN1 CCDC141 MBOAT2 TENM2 HOXA6 ZNF462 FAT2 CSPP1 RASD2	2.77e-05	873	177	18	M16009
Coexpression	WONG_ADULT_TISSUE_STEM_MODULE	MYLK PCLO NIPSNAP1 SLCO3A1 DGKG MYO1B ACTR3B CR2 TENM2 MITF MACF1 PYGM TBX1 PHLDB2 SMAD7 SORL1	3.31e-05	721	177	16	M1999
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2\|Control_saline / Treatment groups by lineage, cell group, cell type	AFF2 MYLK OLFML2B SYT17 SLCO3A1 MYO1B OTOGL KCNS3 LRRC8B	1.19e-07	200	178	9	bc8949eb34482aca166c4602ff6ab876cb4c2c3c
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3\|TCGA-Cervix / Sample_Type by Project: Shred V9	ATP6V1A RIOK3 FAT2 SERPINB13 NFE2L2 MAPK6 CAMSAP1 REV1	5.42e-07	175	178	8	0cc215109d9915af47e4d0a120ce2e46910715fa
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AFF2 OLFML2B SYT17 SLCO3A1 DGKG PAPLN MYO1B KCNS3	7.60e-07	183	178	8	8a799807fbf24456a9811e0c64068187940a2f71
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal-smooth_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK SLCO3A1 DGKG MYO1B CCDC141 OTOGL KLHL23 TBX10	1.05e-06	191	178	8	ff7874cc005760a8f3b2e8072fbe418b6bfacaa8
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SPEF2 TTC21A DNAH7 RSPH10B2 PAX7 CFAP57 DNAH6 CSPP1	1.13e-06	193	178	8	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	AFF2 MYLK OLFML2B SYT17 DGKG MYO1B KCNS3 CSPP1	1.48e-06	200	178	8	786f1ae53e60b5ffbf4bfd393d10b802478148b3
ToppCell	Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	AFF2 MYLK OLFML2B DGKG MYO1B NT5DC2 KLHL23 RASD2	1.48e-06	200	178	8	f9bc22ff17bb1c751e6b05bca3f403836f33459a
ToppCell	Parenchymal-10x5prime-Stromal-Pericyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	AFF2 MYLK OLFML2B DGKG MYO1B NT5DC2 KLHL23 RASD2	1.48e-06	200	178	8	0a7640db28c708003d5da2d19eb651f6fedfd710
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS6KA5 NIPSNAP1 PLEK2 AASS NQO1 TBX1 NOS1AP	3.33e-06	157	178	7	a426c54fd1545093d41426e9620862f71bd06f6b
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPEF2 TTC21A DNAH7 SLC45A2 CFAP57 DNAH6 CSPP1	5.42e-06	169	178	7	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	Ionocyte-iono-2\|World / Class top	GALNT14 ATP6V1A MBOAT2 KCNS3 ATP6V0D2 UNC13A SLC27A2	6.32e-06	173	178	7	e5ec28ccc5e048fd98de4c876e5c53b866b66228
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HYAL4 ATP6V1A SYT17 HCN2 PLEK2 PTPRJ ATP6V0D2	7.33e-06	177	178	7	8e4005fad50e6f919da175f3b9ae58849dbd60b1
ToppCell	facs-Heart-RV-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK1 MYLK SLCO3A1 MYO1B MAGEB16 KLHL23 UNC13A	7.33e-06	177	178	7	7c3d46ebd7e8726be6871aa9763e281fc0ec6ac8
ToppCell	facs-Heart-RV-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK1 MYLK SLCO3A1 MYO1B MAGEB16 KLHL23 UNC13A	7.33e-06	177	178	7	e7b1f3092e6b8d0d580f82648035f5ad12be6961
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HYAL4 ATP6V1A SYT17 PLEK2 PTPRJ HABP2 ATP6V0D2	7.89e-06	179	178	7	27ad6a609fe1f7532b142d0147bccf918704a6dd
ToppCell	droplet-Limb_Muscle-nan-21m-Mesenchymal-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK1 NRAP MYLK DGKG TENM2 PHKG1 PYGM	9.12e-06	183	178	7	6f5dbac2748f50105f0f548d189c42ef14287019
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AFF2 OLFML2B SYT17 DGKG PAPLN MYO1B KCNS3	9.45e-06	184	178	7	689a8af81a79a4bb3123cfa01958c953eab5de98
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA11 TTC21A ZSWIM2 CFAP57 PLEKHA7 DNAH6 CSPP1	9.45e-06	184	178	7	264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AFF2 MYLK OLFML2B SYT17 DGKG PAPLN KCNS3	9.45e-06	184	178	7	102b6f621a5b551e622f97b12d787c080b052a72
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA11 TTC21A ZSWIM2 CFAP57 PLEKHA7 DNAH6 CSPP1	9.45e-06	184	178	7	d7eccbd21c480d907fdc8eff2bf5ae22ae452221
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA11 TTC21A ZSWIM2 CFAP57 PLEKHA7 DNAH6 CSPP1	9.45e-06	184	178	7	22010cfe0428ebfa40952cc1a1a12ad3d25b35c9
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ERCC3 MYO9A AGPAT4 IDE ENPP4 P3H1 MAPK6	9.78e-06	185	178	7	7925519b855f76444a0b57382ce35d89457b0b14
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PCSK1 ITGA11 B3GLCT MYLK CSMD2 PHLDB2 RASD2	9.78e-06	185	178	7	5a0340c25196453f19e424d346efbf66d2c53ac3
ToppCell	COPD-Stromal-Pericyte\|World / Disease state, Lineage and Cell class	AFF2 MYLK DGKG MYO1B TJP1 AASS KLHL23	1.01e-05	186	178	7	8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d
ToppCell	Substantia_nigra-Neuronal\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PCLO TENM2 DLG4 LRRC7 UNC13A DYNC1I1 NOS1AP	1.01e-05	186	178	7	3f889083fcffe516388e9b03a5e23af2010ced33
ToppCell	droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AFF2 OLFML2B MCM5 RFC1 HPF1 KLHL23 REV1	1.05e-05	187	178	7	14c239af77116d28d511dea754b6150d20488080
ToppCell	15-Distal-Mesenchymal-Pericyte\|Distal / Age, Tissue, Lineage and Cell class	OLFML2B SLCO3A1 DGKG MYO1B KLHL23 PYGM KCNS3	1.09e-05	188	178	7	4963382e54aac06bf5047c7d725393db70667ee7
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCSK1 GALNT14 MYLK DGKG KLHL23 PYGM RASD2	1.09e-05	188	178	7	a5e7a363fbd5ae4d9312cf6f9941413d6a5c0b4d
ToppCell	facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TM9SF3 KAT6A NEK7 STT3A SNX13 MTMR6 MACF1	1.12e-05	189	178	7	875df61ee48baa5142ba4d2427bdec1c53e5a828
ToppCell	Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175\|Adult / Lineage, Cell type, age group and donor	ATP6V1A XPO1 EHBP1L1 PTPRJ MITF ATP6V0D2 CAMSAP1	1.25e-05	192	178	7	733491e932350e3c216a626cc49c3cd3fe970a82
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 MYO9A PCLO DNAH7 PTPRJ MITF PLEKHA7	1.33e-05	194	178	7	93c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPEF2 TTC21A DNAH7 NQO1 CFAP57 DNAH6 CSPP1	1.38e-05	195	178	7	649fd2336e963f6a150d182a53ad5dd838ca80b1
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 MYO9A PCLO DNAH7 PTPRJ PLEKHA7 NOS1AP	1.38e-05	195	178	7	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPEF2 TTC21A DNAH7 NQO1 CFAP57 DNAH6 CSPP1	1.38e-05	195	178	7	129ad5f4253ecb1a8477cc38773e6e91ea9570b0
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPEF2 TTC21A DNAH7 NQO1 CFAP57 DNAH6 CSPP1	1.38e-05	195	178	7	3e70ee987d66d450062d5df3d7c733ccc7344470
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 MYO9A PCLO DNAH7 PTPRJ MITF PLEKHA7	1.42e-05	196	178	7	6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 MYO9A PCLO DNAH7 PTPRJ MITF PLEKHA7	1.42e-05	196	178	7	eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Pericyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	OLFML2B PON2 DGKG MYO1B TJP1 NT5DC2 KCNS3	1.47e-05	197	178	7	44cd1ece3633a31e8c9b667cd3cbc2749c06f478
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NRAP SPEF2 TTC21A PAPLN DNAH7 HABP2 DNAH6	1.47e-05	197	178	7	6e4a411ef823ce9e16f420e185e21fa19d13af34
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Pericyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	AFF2 OLFML2B DGKG MYO1B TJP1 NT5DC2 KCNS3	1.52e-05	198	178	7	76d46950c11cb4708866db0da54ce00d5c0adab8
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	PCLO SMC6 ARFGEF1 RFC1 BPTF NQO1 ANKRD11	1.57e-05	199	178	7	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	AFF2 MYLK OLFML2B DGKG MYO1B TENM2 KCNS3	1.62e-05	200	178	7	b5b5a32925f225610fe25a021a742d6397162863
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	AFF2 MYLK OLFML2B DGKG MYO1B NT5DC2 KLHL23	1.62e-05	200	178	7	0c648941447c738caf62f2d71e296d6cca492c8b
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	AFF2 MYLK OLFML2B SYT17 DGKG MYO1B KCNS3	1.62e-05	200	178	7	d2fcd3bd7c3223875f027eeb48ff621192a5f242
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	AFF2 MYLK OLFML2B DGKG MYO1B TENM2 KCNS3	1.62e-05	200	178	7	b22cae282591d8dead9869c2adbb9632615f50f7
ToppCell	Tracheal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	AFF2 MYLK OLFML2B DGKG MYO1B OTOGL KLHL23	1.62e-05	200	178	7	8158f4eaeff945a6788c8e732b7a1b0d78052a06
ToppCell	(09)_Interm._secr.>cil.\|World / shred by cell type by condition	SPEF2 DNAH7 RSPH10B2 CFAP57 DNAH6 CSPP1 RSPH10B	1.62e-05	200	178	7	3305e14dba12e94da42f0414fdc7a2c8caf0a183
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AFF2 MYLK OLFML2B DGKG MYO1B NT5DC2 KLHL23	1.62e-05	200	178	7	522a51a284d2992d519c4669e1a48c8ebcc08c80
ToppCell	Tracheal-10x3prime_v2-Stromal-Pericyte\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	AFF2 MYLK OLFML2B DGKG MYO1B OTOGL KLHL23	1.62e-05	200	178	7	600d56257b1b0cda8ed2fd0db92c6551711f7d6d
ToppCell	Bronchial-10x5prime-Stromal-Pericyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	AFF2 MYLK DGKG MYO1B NT5DC2 KLHL23 RASD2	1.62e-05	200	178	7	362706445edb33b313684efe50b1f44f5f816e67
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	AFF2 MYLK OLFML2B DGKG MYO1B NT5DC2 KLHL23	1.62e-05	200	178	7	94f1fa61aa82eb9f411b2b1cb759476939ab5db7
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte\|Control_saline / Treatment groups by lineage, cell group, cell type	AFF2 MYLK OLFML2B DGKG MYO1B TENM2 KCNS3	1.62e-05	200	178	7	cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c
ToppCell	facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZSWIM2 PLEK2 CCNB3 OTOGL LRRC7 PAX7	2.22e-05	141	178	6	4aa4b3476dc5abefbd348353cfe711cd5fe3d52f
ToppCell	facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZSWIM2 PLEK2 CCNB3 OTOGL LRRC7 PAX7	2.22e-05	141	178	6	e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8
ToppCell	Control-Epithelial_alveolar-AT_1-AT2_Progenitor\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PAPLN CR2 TIGD5 TBX1 SLC27A2 RASD2	2.31e-05	142	178	6	94e277f038f4006d99ff50222b0f5cf89bc3d46d
ToppCell	facs-Heart-Unknown-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZSWIM2 PLEK2 CCNB3 OTOGL LRRC7 PAX7	2.31e-05	142	178	6	759fbbd15b4fb313bd6269b7f087edafebd530ef
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ATP6V1A SYT17 ESRP1 PTPRJ NFE2L2 ATP6V0D2	3.15e-05	150	178	6	87968ce885a4959616f0321f58517fe8029ba1b1
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HYAL4 ATP6V1A SYT17 PLEK2 PTPRJ ATP6V0D2	4.51e-05	160	178	6	174a4ab27114efcc63be36929b80680be3c35c9b
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PIGB SLC25A42 NADK2 TFR2 AATK TIGD5	4.51e-05	160	178	6	8374ae912337947b2cc8d17d5840f306361fe1ff
ToppCell	BAL-Mild-cDC_5\|Mild / Compartment, Disease Groups and Clusters	SLC25A42 IFT172 RSPH10B2 PHKG1 AATK DCLK2	4.67e-05	161	178	6	7a6e8ed0b5d999efce8945d8083ab01d71be9a92
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_5\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PON2 RSPH10B2 PHKG1 CD1C AATK DCLK2	4.67e-05	161	178	6	78cc5bc488bc47726195a649946d414e6bfabf94
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_5\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PON2 RSPH10B2 PHKG1 CD1C AATK DCLK2	4.84e-05	162	178	6	0fa93efc9c005d1e649b3f7069ae8641d6e41ed8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HYAL4 ATP6V1A SYT17 PTPRJ GNA11 ATP6V0D2	5.18e-05	164	178	6	83141be8dfed85511ea6afda7c76ff4b6b5ef021
ToppCell	3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PCLO PLEK2 SERPINB13 IL20 NT5DC2 SLC45A2	5.54e-05	166	178	6	9fd9de82f98b9acdaa59ac98fb9664161514aec0
ToppCell	facs-Tongue-nan-3m-Epithelial-basal\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYT17 COLGALT2 TGIF1 IL20 BEND7 LRRC8B	5.92e-05	168	178	6	ca0c4a819f9047fc40d224f7656fec60f6fa05d8
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPEF2 TTC21A DNAH7 CFAP57 DNAH6 RSPH10B	6.12e-05	169	178	6	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HYAL4 ATP6V1A SYT17 PLEK2 PTPRJ ATP6V0D2	6.12e-05	169	178	6	4b3a7b4a497178799b6b2f0b744f5fb752cee31a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HYAL4 ATP6V1A SYT17 PLEK2 PTPRJ ATP6V0D2	6.12e-05	169	178	6	a4fd646b9bf87225131fca530bd6b52df9eaf489
ToppCell	E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Uncommitted_AE_cell\|E16.5-samps / Age Group, Lineage, Cell class and subclass	NIPSNAP1 PLEK2 HABP2 FLRT3 MAPK6 PLEKHA7	6.32e-05	170	178	6	5a64e05c263df915085988d881808221e2c0f2e2
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLCO3A1 MYO1B VSX1 FMO6P CCNB3 KCNS3	6.32e-05	170	178	6	17bd7fd25a2657cb536ad47e294332920f759e95
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OLFML2B SYT17 SMC6 PAPLN OTOGL KCNS3	6.32e-05	170	178	6	5570c0e825bca77613bf0ebde620cf744fa1cb84
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9\|TCGA-Bladder / Sample_Type by Project: Shred V9	NCOA3 SLCO3A1 FAT2 SERPINB13 NFE2L2 MAPK6	6.53e-05	171	178	6	adbcfa4bf6bc1c604535a24435924cdb091e2dd7
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCLO NQO1 FLRT3 PLEKHA7 DNAH6 TBX1	7.42e-05	175	178	6	f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69
ToppCell	3'-Adult-Appendix-Epithelial-mature_enterocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACTR3B LCT CR2 ACTR3 DCLK2 DAGLA	7.66e-05	176	178	6	30adf8f1638c6244586f8101c2590bb964dfae00
ToppCell	3'-Adult-Appendix-Epithelial-mature_enterocytic-Colonocyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACTR3B LCT CR2 ACTR3 DCLK2 DAGLA	7.66e-05	176	178	6	23fa02d4c39e0b8faa1658116d50b6233a952ccc
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AFF2 MYLK OLFML2B DGKG MYO1B NT5DC2	7.90e-05	177	178	6	452ec2df36c6d656a7cdadc55be545ccdb146a29
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 AFF2 DGKG MYO1B COLGALT2 DYNC1I1	7.90e-05	177	178	6	a8625d14682183cf77cb51eaf11bc15a3528f586
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 AFF2 DGKG MYO1B COLGALT2 DYNC1I1	7.90e-05	177	178	6	3645e2f4a48283f290f85c49c3e79e3f58ac9aa6
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK DGKG MYO1B CPN1 CR2 CFAP57	8.15e-05	178	178	6	7467e5ab2fcb39cc4a2c7dd69722c91def3b6aea
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HYAL4 ATP6V1A SYT17 PLEK2 GNA11 ATP6V0D2	8.15e-05	178	178	6	f1cfc348d51362eb8c92c625f21f682afc0352b7
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPEF2 TTC21A DNAH7 NQO1 CFAP57 DNAH6	8.15e-05	178	178	6	3b12db04006db6e94fc45649a4b3a63b92f21a61
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAX TFR2 GXYLT2 KLHL23 KAT6B CDK6	8.40e-05	179	178	6	e880c507f11ce75d104593a4ca29f0295f8125e8
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AFF2 MYLK DGKG HOXA6 OTOGL NT5DC2	8.40e-05	179	178	6	dc6cd46fa652b296ddbc41855f6377946d0a4cdc
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLC25A42 PCLO OTOGL LRRC7 FUT6 SLC27A2	8.66e-05	180	178	6	f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e
ToppCell	facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NRAP SYT17 ACTR3B TFR2 NT5DC2 KCNS3	8.93e-05	181	178	6	ebf1ae963a2b22e1772752ed85a4fb0e546d377e
ToppCell	droplet-Lung-nan-3m-Epithelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESRP1 CPN1 CCDC141 AASS FLRT3 RASD2	9.21e-05	182	178	6	cfba75c1ffc39ac76db9e8e27394731942882b30
ToppCell	droplet-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESRP1 CPN1 CCDC141 AASS FLRT3 RASD2	9.21e-05	182	178	6	d836bfdc298ecd3558a973e393a329eb8bd59d79
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GALNT14 ITGA11 OLFML2B MBOAT2 OTOGL DNAH6	9.21e-05	182	178	6	205d9ad1ea4b7adee8054496cdde46c9c401a19a
ToppCell	droplet-Lung-nan-3m-Epithelial-type_II_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESRP1 CPN1 CCDC141 AASS FLRT3 RASD2	9.21e-05	182	178	6	7e7c7a26460d3003cdf0c0ffb96208a566aa09a7
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALX3 MYLK DGKG OTOGL KCNS3 PHLDB2	9.78e-05	184	178	6	89ae8bf1a6c2d355d279d23a5e24a08d9ec2334e
ToppCell	COPD-Stromal-Pericyte\|COPD / Disease state, Lineage and Cell class	AFF2 MYLK OLFML2B MYO1B AASS KLHL23	9.78e-05	184	178	6	a56264a22dfc2d3672b20134ab7c3c7c23da5ae1
ToppCell	facs-Heart-RV-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK MYO1B CCDC141 AATK KLHL23 SORL1	9.78e-05	184	178	6	9c20b50f8d6ac689d41d5440c835f9db8d04758b
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	B3GLCT CSMD2 TENM2 ZNF462 FLRT3 TBX1	9.78e-05	184	178	6	658f2e522055e88c92bc482a845c40f8f5f1a8e3
ToppCell	facs-Heart-RV-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK MYO1B CCDC141 AATK KLHL23 SORL1	9.78e-05	184	178	6	31dbe6119a3bcd266ae5e9b340c853d9ff680dce
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALX3 MYLK DGKG OTOGL KCNS3 PHLDB2	9.78e-05	184	178	6	34c84ac9a32eaf96f45b79485119cad65905817d
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	XPO1 ENPP4 KIF14 MACF1 SLC27A2 CDK6	1.01e-04	185	178	6	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	10x3'2.3-week_14-16-Myeloid_macrophage-stroma-osteoclast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ATP6V1A MYO1B ZNF462 MITF SLC45A2 ATP6V0D2	1.01e-04	185	178	6	5ed49b6d8214c6119355a6d3ee4e25d40bcc0c53
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK1 PON2 PAPLN AASS PYGM PLEKHA7	1.07e-04	187	178	6	dd1d91f101b837bba513f77defa6e6902b2c0570
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	AFF2 OLFML2B DGKG MYO1B TJP1 KLHL23	1.07e-04	187	178	6	fa01a61bfd13feb033ba1e35cf513707b1bff8c8
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	AFF2 DGKG TJP1 OTOGL NT5DC2 KLHL23	1.07e-04	187	178	6	86250acf088ec0c4800a0dfa031b0d4f7e52c342
Disease	Paroxysmal atrial fibrillation	USP34 XPO1 ZNF462 GTF2I PHLDB2 SMAD7 SORL1 CDK6	4.48e-06	156	175	8	C0235480
Disease	familial atrial fibrillation	USP34 XPO1 ZNF462 GTF2I PHLDB2 SMAD7 SORL1 CDK6	4.48e-06	156	175	8	C3468561
Disease	Persistent atrial fibrillation	USP34 XPO1 ZNF462 GTF2I PHLDB2 SMAD7 SORL1 CDK6	4.48e-06	156	175	8	C2585653
Disease	Atrial Fibrillation	USP34 XPO1 ZNF462 GTF2I PHLDB2 SMAD7 SORL1 CDK6	5.41e-06	160	175	8	C0004238
Disease	QRS duration	USP34 OLFML2B UBR4 XPO1 CCDC141 PTPRJ MITF DYNC1I1 NOS1AP CDK6	1.25e-05	298	175	10	EFO_0005055
Disease	Mainzer-Saldino Disease	IFT140 IFT172	3.50e-05	2	175	2	C1849437
Disease	neutrophil count	MYO1G OLFML2B NEK7 DGKG RIOK3 MYO1B XPO1 LCT SNX13 TGIF1 CD1C TRAP1 AATK LRRC25 PTPRJ BEND7 MITF ANKRD11 ATP6V0D2 NOS1AP CDK6	7.56e-05	1382	175	21	EFO_0004833
Disease	Ptosis	ZNF462 PAX7	1.05e-04	3	175	2	C0033377
Disease	Blepharoptosis	ZNF462 PAX7	1.05e-04	3	175	2	C0005745
Disease	C-reactive protein measurement	PCSK1 USP34 OLFML2B IFT172 BAAT THUMPD3 NEK7 ZNF226 BPTF TLK1 GTF2I LRRC25 NFE2L2 MACF1 SHE DLG4 CTNNA1 MAPK6 DAGLA	1.06e-04	1206	175	19	EFO_0004458
Disease	eotaxin measurement	OLFML2B RAX TBC1D22A HABP2 NOS1AP	1.16e-04	80	175	5	EFO_0008122
Disease	alkaline phosphatase measurement	USP34 RPS6KA5 NEK7 PAPLN MYO1B VSX1 PLEKHM1 SNX13 TGIF1 TLK1 PTPRJ MITF MACF1 DLG4 CDC5L FUT6 SMAD7	1.21e-04	1015	175	17	EFO_0004533
Disease	alcohol consumption measurement	DOCK1 RPS6KA5 IFT172 PCLO ZSWIM2 RIOK3 FBXO11 PAPLN RFC1 MBOAT2 TENM2 LRRC25 PTPRJ NFE2L2 NQO1 ANKRD11 CTNNA1 MAPK6 SORL1	1.55e-04	1242	175	19	EFO_0007878
Disease	DiGeorge syndrome (implicated_via_orthology)	DOCK1 KAT6A TBX1	1.85e-04	19	175	3	DOID:11198 (implicated_via_orthology)
Disease	Alzheimer's disease biomarker measurement	AGPAT4 MCM5 SORL1 RASD2	1.90e-04	48	175	4	EFO_0006514
Disease	Orofacial cleft, alcohol consumption measurement	SLCO3A1 PAX7	2.08e-04	4	175	2	EFO_0007878, HP_0000202
Disease	rosacea severity measurement	LINC01619 PCLO EHBP1L1 SLC45A2 DCLK2 ATP6V0D2	2.53e-04	147	175	6	EFO_0009180
Disease	otitis media (implicated_via_orthology)	FBXO11 TGIF1 TBX1	2.91e-04	22	175	3	DOID:10754 (implicated_via_orthology)
Disease	familial long QT syndrome	OLFML2B NOS1AP	3.46e-04	5	175	2	MONDO_0019171
Disease	total blood protein measurement	NCOA3 RIOK3 XPO1 SNX13 TLK1 EHBP1L1 MACF1 LRRC8B ATP6V0D2 CDK6	3.70e-04	449	175	10	EFO_0004536
Disease	cortical surface area measurement	ALX3 USP34 ITGA11 APC XPO1 DNAH7 TENM2 PLEKHM1 SNX13 TJP1 TBC1D22A NT5DC2 MACF1 KCNS3 PAX7 CDC5L MAPK6 PLEKHA7 CDK6	4.21e-04	1345	175	19	EFO_0010736
Disease	Hereditary Nonpolyposis Colorectal Neoplasms	APC PTPRJ CTNNA1	4.82e-04	26	175	3	C0009405
Disease	myeloid white cell count	MYO1G USP34 DGKG RIOK3 MYO1B XPO1 LCT SNX13 TRAP1 LRRC25 PTPRJ BEND7 ATP6V0D2 SORL1 CDK6	4.92e-04	937	175	15	EFO_0007988
Disease	Hereditary Nonpolyposis Colorectal Cancer	APC PTPRJ CTNNA1	6.69e-04	29	175	3	C1333990
Disease	focal segmental glomerulosclerosis (implicated_via_orthology)	MYO9A ACTR3	7.20e-04	7	175	2	DOID:1312 (implicated_via_orthology)
Disease	Albinism, Oculocutaneous	MITF SLC45A2	7.20e-04	7	175	2	C0078918
Disease	glypican-1 measurement	NRAP HABP2	7.20e-04	7	175	2	EFO_0801649
Disease	melanoma	ERCC3 UBR4 MYO1B RAX MITF SLC45A2 GNA11	7.27e-04	248	175	7	C0025202
Disease	Williams Syndrome	GTF2I DLG4	9.57e-04	8	175	2	C0175702
Disease	neonatal abstinence syndrome	DOCK1 SNX13 SLC27A2 NOS1AP	1.15e-03	77	175	4	EFO_0005799
Disease	3-hydroxy-1-methylpropylmercapturic acid measurement	DOCK1 USP34 SYT17 SPEF2 SLCO3A1 BEND2 PTPRJ PRMT3	1.25e-03	352	175	8	EFO_0007015
Disease	longitudinal BMI measurement	DOCK1 PCSK1 KCNS3 NOS1AP	1.46e-03	82	175	4	EFO_0005937
Disease	Intellectual Disability	PIGB APC STT3A ZNF462 BPTF AASS ALG14 MACF1 DLG4	1.46e-03	447	175	9	C3714756
Disease	lung non-small cell carcinoma (is_implicated_in)	ERCC3 FBXO11 XPO1 NQO1 CDK6	1.47e-03	139	175	5	DOID:3908 (is_implicated_in)
Disease	HVA measurement, MHPG measurement	B3GLCT MYO9A CSMD2	1.72e-03	40	175	3	EFO_0005131, EFO_0005133
Disease	atrial fibrillation	USP34 XPO1 ZNF462 GTF2I PHLDB2 SMAD7 SORL1 CDK6	1.75e-03	371	175	8	EFO_0000275
Disease	neutrophil count, eosinophil count	MYO1G XPO1 TRAP1 LRRC25 PTPRJ CDK6	1.76e-03	213	175	6	EFO_0004833, EFO_0004842
Disease	Cutaneous Melanoma	ERCC3 MITF GNA11	1.85e-03	41	175	3	C0151779
Disease	Familial Atypical Mole Melanoma Syndrome	ACD MITF	1.86e-03	11	175	2	C2314896
Disease	Jeune thoracic dystrophy	IFT140 IFT172	1.86e-03	11	175	2	C0265275
Disease	colon cancer (implicated_via_orthology)	APC NQO1	1.86e-03	11	175	2	DOID:219 (implicated_via_orthology)
Disease	Childhood Medulloblastoma	KAT6A APC CDK6	2.13e-03	43	175	3	C0278510
Disease	Melanotic medulloblastoma	KAT6A APC CDK6	2.13e-03	43	175	3	C1275668
Disease	Medullomyoblastoma	KAT6A APC CDK6	2.13e-03	43	175	3	C0205833
Disease	Desmoplastic Medulloblastoma	KAT6A APC CDK6	2.13e-03	43	175	3	C0751291
Disease	Adult Medulloblastoma	KAT6A APC CDK6	2.13e-03	43	175	3	C0278876
Disease	Gastrointestinal Diseases	MYLK NFE2L2	2.22e-03	12	175	2	C0017178
Disease	level of C-X-C motif chemokine 2 in blood serum	OLFML2B NOS1AP	2.22e-03	12	175	2	OBA_2041207
Disease	Functional Gastrointestinal Disorders	MYLK NFE2L2	2.22e-03	12	175	2	C0559031
Disease	Cholera Infantum	MYLK NFE2L2	2.22e-03	12	175	2	C1565321
Disease	phenylacetylglutamine measurement	B3GLCT LRRC8B	2.22e-03	12	175	2	EFO_0021013
Disease	gallbladder carcinoma (is_marker_for)	ACTR3 TJP1	2.22e-03	12	175	2	DOID:4948 (is_marker_for)
Disease	Non-Small Cell Lung Carcinoma	NCOA3 APC ZNF462 NFE2L2 NQO1	2.43e-03	156	175	5	C0007131
Disease	osteoarthritis, knee	NT5DC2 DCLK2 PAX7 MAPK6 DYNC1I1	2.57e-03	158	175	5	EFO_0004616
Disease	mood disorder	FLRT3 SORL1	2.61e-03	13	175	2	EFO_0004247
Disease	liver cirrhosis (implicated_via_orthology)	NFE2L2 NQO1	2.61e-03	13	175	2	DOID:5082 (implicated_via_orthology)
Disease	Short Rib-Polydactyly Syndrome	IFT140 IFT172	2.61e-03	13	175	2	C0036996
Disease	respiratory quotient	AATK UNC13A	3.04e-03	14	175	2	EFO_0005189
Disease	chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology)	TBX10 TBX1	3.04e-03	14	175	2	DOID:0060413 (implicated_via_orthology)
Disease	Saldino-Noonan Syndrome	IFT140 IFT172	3.04e-03	14	175	2	C0036069
Disease	Majewski Syndrome	IFT140 IFT172	3.04e-03	14	175	2	C0024507
Disease	pulmonary emphysema (is_marker_for)	NFE2L2 NQO1	3.04e-03	14	175	2	DOID:9675 (is_marker_for)
Disease	T wave morphology measurement	OLFML2B NOS1AP	3.04e-03	14	175	2	EFO_0008398
Disease	basophil count, eosinophil count	LINC01619 SPEF2 XPO1 BPTF SERPINB13 CDK6	3.25e-03	241	175	6	EFO_0004842, EFO_0005090
Disease	Medulloblastoma	KAT6A APC CDK6	3.28e-03	50	175	3	C0025149
Disease	QRS amplitude, QRS complex	OLFML2B MITF NOS1AP	3.28e-03	50	175	3	EFO_0005054, EFO_0007742
Disease	Williams-Beuren syndrome (implicated_via_orthology)	GTF2I DLG4	3.49e-03	15	175	2	DOID:1928 (implicated_via_orthology)
Disease	level of C-X-C motif chemokine 3 in blood serum	OLFML2B NOS1AP	3.49e-03	15	175	2	OBA_2041208
Disease	pancreatic adenocarcinoma (is_implicated_in)	SMAD7 CDK6	3.49e-03	15	175	2	DOID:4074 (is_implicated_in)
Disease	facial width measurement	SPEF2 PCLO HABP2 DYNC1I1	3.59e-03	105	175	4	EFO_0007855
Disease	Schizoaffective disorder-bipolar type	MYO1G PCLO	3.97e-03	16	175	2	EFO_0009965
Disease	Hepatomegaly	MYO1B MBOAT2 NFE2L2	4.07e-03	54	175	3	C0019209
Disease	granulocyte count	MYO1G XPO1 TRAP1 LRRC25 PTPRJ CDK6	4.19e-03	254	175	6	EFO_0007987
Disease	Cholestasis	BAAT NFE2L2 NQO1 SORL1	4.24e-03	110	175	4	C0008370
Disease	Eye Abnormalities	APC VSX1	4.49e-03	17	175	2	C0015393
Disease	Malignant neoplasm of breast	NCOA3 TPTE ERCC3 UBR4 SMC6 DGKG COLGALT2 OTOGL BEND7 NQO1 MACF1 LRRC7 KAT6B SORL1	4.96e-03	1074	175	14	C0006142
Disease	irritable bowel syndrome symptom measurement	ACTR3B SNX13 CDK6	4.98e-03	58	175	3	EFO_0021536
Disease	Meckel syndrome type 1	KIF14 CSPP1	5.03e-03	18	175	2	C3714506
Disease	Idiopathic hypogonadotropic hypogonadism	CCDC141 FLRT3	5.03e-03	18	175	2	C0342384
Disease	heart failure	LINC01619 CCDC141 BPTF GTF2I CDK6	5.03e-03	185	175	5	EFO_0003144
Disease	Polydactyly	ALX3 IFT140 IFT172 CSPP1	5.27e-03	117	175	4	C0152427
Disease	atrophic macular degeneration, age-related macular degeneration, wet macular degeneration	B3GLCT SPEF2 FUT6	5.48e-03	60	175	3	EFO_0001365, EFO_0004683, EFO_1001492
Disease	macula measurement	MYO9A RAX2 BPTF PLEKHA7 SORL1	5.50e-03	189	175	5	EFO_0008375
Disease	Congenital Myasthenic Syndromes, Presynaptic	MYO9A ALG14	5.60e-03	19	175	2	C0751884
Disease	skin sensitivity to sun	ANKRD11 SLC45A2	5.60e-03	19	175	2	EFO_0004795
Disease	acute lymphoblastic leukemia, response to antineoplastic agent	NCOA3 PRMT3	5.60e-03	19	175	2	EFO_0000220, GO_0097327
Disease	Hereditary Non-Polyposis Colon Cancer Type 2	PTPRJ CTNNA1	5.60e-03	19	175	2	C1333991
Disease	abnormal paneth cell measurement	SPEF2 ACTR3B	5.60e-03	19	175	2	EFO_0007963
Disease	Colorectal cancer, hereditary nonpolyposis, type 1	PTPRJ CTNNA1	5.60e-03	19	175	2	C2936783
Disease	acute kidney failure (biomarker_via_orthology)	NFE2L2 NQO1 TBX1	5.74e-03	61	175	3	DOID:3021 (biomarker_via_orthology)
Disease	colorectal cancer (is_implicated_in)	APC XPO1 PTPRJ SMAD7	5.93e-03	121	175	4	DOID:9256 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
HELYSREYQTDPAKK	UNC13A	1016	Q9UPW8
PVNRKYEYLDHTADV	ZBTB8OS	26	Q8IWT0
FASLALAYHNYEDLP	BAAT	186	Q14032
EHITYLEHNPYEKFS	CDC5L	611	Q99459
EAHLTEDQIFYFPKY	C8G	171	P07360
AIEPYHSDRANPYFE	ANKRD11	2426	Q6UB99
FHQARPVDYPKDYLS	B3GLCT	441	Q6Y288
RPGFKLEYQDLTYSH	CSMD2	2066	Q7Z408
VFQKTHYPDVYAREQ	ALX3	171	O95076
ISDNRFKAHASFYYP	ARFGEF1	1791	Q9Y6D6
PKLTFDDSVHNADYY	AFF2	1061	P51816
VVFKYLRAEPEDHYF	ACTR3B	96	Q9P1U1
ALHPEQKADRYFVLY	ASCC2	26	Q9H1I8
ERIYLYHNSLDEFPT	FLRT3	86	Q9NZU0
ILQLDEVDFYYDPKH	ABCF3	491	Q9NUQ8
EVDFYYDPKHVIFSR	ABCF3	496	Q9NUQ8
PAEYDKHPERYISRF	AASS	281	Q9UDR5
AYSALSHPYFQDLER	CDK6	291	Q00534
NAYSPRHYVIADTDE	ALG14	61	Q96F25
SDKEYHHVLPYQEAE	BPTF	336	Q12830
RDPFYVDQYEQEHIK	CAMSAP1	61	Q5T5Y3
SFADHVVPLLEYYRD	CDAN1	701	Q8IWY9
FANIEEDTPSYHRRY	EFR3A	126	Q14156
KFEEHNSPRVDDFVY	CCNB3	1216	Q8WWL7
YNHRFSDPERVNYKF	ESRP1	196	Q6NXG1
QLERAFEASHYPDVY	RAX2	41	Q96IS3
YPDVYSREELAAKVH	RAX2	51	Q96IS3
PHLEAALQEYFVAYE	P3H1	226	Q32P28
VENHYKLSLPEDFYH	HPF1	41	Q9NWY4
PLDHESYEFKVISQY	PARP2	371	Q9UGN5
ELEKAFERTHYPDIY	PAX7	231	P23759
FLDHKTLYYDVEPFL	KAT6B	811	Q8WYB5
ERDKFFQSHYTYNPQ	KIAA0895L	151	Q68EN5
AYHIYHEEFQKRSPS	RSPH10B	501	P0C881
AYHIYHEEFQKRSPS	RSPH10B2	501	B2RC85
EHPDTKQVYNFIYDV	KIF14	391	Q15058
HPSADVLKYTYEDFK	PTPRJ	861	Q12913
PDHEYKFRVRAINVY	MYLK	1396	Q15746
DYLHFSPEQQYKPDS	HOXA6	101	P31267
YPHSFPSQYAEALKE	MAGEB16	301	A2A368
EVDPIRHYYAFFSKL	MAGEB18	166	Q96M61
FFDDDYDYLQHLKEP	LTV1	61	Q96GA3
RHYFIEPSQLKLFYD	MBOAT2	401	Q6ZWT7
DEDLADYLYKQPAEH	MCM5	81	P33992
ADYKHDIVDYNYPAT	NRAP	446	Q86VF7
YRTQYHKFTALPEDL	NRAP	1381	Q86VF7
FPVLSYYHQDKEAAI	MTMR6	186	Q9Y217
RYEDEHPSYQEVKAQ	LRRC7	1171	Q96NW7
VRYTHSFPEALQKFY	NADK2	196	Q4G0N4
HTGDPKQDLAYERQY	EIF3L	26	Q9Y262
AHPSEDNDFYINYKD	LRRC25	261	Q8N386
FKEYQEEAYSISLHP	CFAP57	426	Q96MR6
HLRRYSYNSEEVDFP	BEND2	141	Q8NDZ0
HNKPLYSFEDNADYV	DYNC1I1	521	O14576
PEKFRYAQDDFVLDH	DCLK2	271	Q8N568
TLPEDRFGYRDDHYQ	PCLO	2961	Q9Y6V0
KYSPEFQQHLYEAEL	FAT2	2476	Q9NYQ8
REKYLEDPAFDTNYS	MAPK6	406	Q16659
YNRKDGKPFDEHDEY	PDE6C	406	P51160
HPNVIKYYASFIEDN	NEK7	91	Q8TDX7
PEAKLTEVDNYHFYS	NFE2L2	216	Q16236
AYHNPDARTYEDKRA	CSPP1	701	Q1MSJ5
FRADYLKNYEFPHLQ	ENPP4	36	Q9Y6X5
YHDDKQPTFRALYEA	GXYLT2	366	A0PJZ3
LHRFYPDKIDYASLD	EHBP1L1	1076	Q8N3D4
YYEFVAALHPNKDAY	MACF1	3226	O94854
PNTEDTDRIFYHKTY	LCT	1281	P09848
SVADKEYYFDRNPSL	KCNS3	61	Q9BQ31
FRGNYLHSRDYKNPE	FMO6P	166	O60774
DSPFYQHYDLDLKDK	RPS6KA5	416	O75582
SHYEVKPNSSLERYD	ITGA11	966	Q9UKX5
DTSIDYNPLYKERHQ	DDX23	281	Q9BUQ8
HLADQYDPLYSKRFS	LRRC8B	371	Q6P9F7
FQYPAESVLAYKEGH	NQO1	66	P15559
AKELDPRYEDYVDQH	IFT172	1381	Q9UG01
DDPYKLYAFNQRESE	GALNT14	71	Q96FL9
NDHYFSDPFLKYLET	PON2	181	Q15165
LDHKTLYYDVEPFLF	KAT6A	601	Q92794
LKQYDPHEPISYDVF	DGKG	41	P49619
FKYSHYNERDEIPHN	HABP2	396	Q14520
VIFKYLRAEPEDHYF	ACTR3	96	P61158
AYPKYTFHDREEVVK	DNAH6	166	Q9C0G6
KFYDADDYHPEENRR	IDNK	31	Q5T6J7
QEDYIYLFKDSTHPV	KLHL23	6	Q8NBE8
VANYPYDKSFEHRVR	CPN1	221	P15169
EDFHYDYIDLLKEPA	CCDC141	1131	Q6ZP82
FHLEAREVYSVDPYN	CR2	1016	P20023
YEKAFFTDRYLQEHP	DOCK1	1541	Q14185
HPDVAAYKANRDLIY	CTNNA1	231	P35221
DHASQDYSKYPFEVQ	CD1C	101	P29017
ESYRDFIYQNPHIFK	PRMT3	241	O60678
EHFYSNPARYKGREN	FBXO11	251	Q86XK2
DKILYSHLVDYFPEF	GNA11	281	P29992
APTEHLRLYDKYDFL	DNAH7	486	Q8WXX0
HLEKADQDINYYIPA	HYAL4	121	Q2M3T9
RPYFTIHDSEFKEYT	DENND6A	326	Q8IWF6
KFYLAFENSLHPDYI	FUT6	241	P51993
QYKPEEYSRFEAKIH	DLG4	391	P78352
AVYETPFYVAVDHDK	DAGLA	376	Q9Y4D2
DYHHEVYKIPEFSND	BEND7	21	Q8N7W2
HENDERPFYQKTAPY	CSN3	31	P07498
LDRVFKNYQTPDHYT	IL20	91	Q9NYY1
YPKENEYSQFLSEHA	IDE	121	P14735
YFPLDEHVDHYSRTK	SDR42E2	166	A6NKP2
HLEYPLLAEYDFRND	ERCC3	286	P19447
DPIYRIFYVSHDSQD	NOS1AP	111	O75052
EASDKLTFYPPHQDY	COLGALT2	246	Q8IYK4
PYQKFEAHPNDLYVE	GTF2I	491	P78347
PYSAHNSTEFLIYER	SLC45A2	351	Q9UMX9
KLPADFRQKIHDYYE	HCN2	491	Q9UL51
LSYYEKSDTHRFEVP	IFT140	921	Q96RY7
SAERPNYFLYVHDND	OTOGL	1276	Q3ZCN5
QHEYAAPADYFRILV	NUP58	336	Q9BVL2
HSAQDFYENYEPKEI	PHKG1	11	Q16816
FHNVKPEYLDAYNSL	NIPSNAP1	76	Q9BPW8
HEYYQPTALLRDAEE	PLEKHM1	146	Q9Y4G2
KSHYLDEADVFYLNP	PIGB	466	Q92521
KASPALAHYVYDFLE	SNX13	671	Q9Y5W8
KHPFIQDLISNYSDY	SPEF2	1776	Q9C093
QFYHSPADNKRYIFA	SORL1	166	Q92673
PADNKRYIFADAYAQ	SORL1	171	Q92673
PEFLTHQYKYEAGEI	SLCO3A1	126	Q9UIG8
RTYNPDDYFRKFEPH	SYT17	146	Q9BSW7
DDYFRKFEPHLYSLD	SYT17	151	Q9BSW7
LNEKNPYRDSAYFSD	AATK	986	Q6ZMQ8
AFTRAYNKEAHLTPY	RFC1	1061	P35251
KLFQHIADYLPSYAR	SLC27A2	541	O14975
EAYLNGHAETPVYRF	NCOA3	321	Q9Y6Q9
LPSDYKYAQDRASHL	PLEKHA7	491	Q6IQ23
HIKENDYYTPTGEFR	STT3A	611	P46977
YDPLTKLVHFTQRDY	TENM2	2416	Q9NT68
VPYAAIQFSAHEEYK	SLC25A42	101	Q86VD7
AYAHPEYEERFLQEE	OLFML2B	236	Q68BL8
YPDHSYKDQAFDTLS	PHLDB2	991	Q86SQ0
YPKHEGIFSTLNRDY	SOX30	656	O94993
LERAFEKSHYPDVYS	RAX	151	Q9Y2V3
KRHRDGSAFQYEYEP	ACD	406	Q96AP0
YNEEKRHVDQPIDYS	APC	1166	P25054
YPLQVYQLHFESSDK	LINC01619	91	G3V211
ISFENYRKVHPYEDS	RIOK3	111	O14730
DFIPLDDKRYRYAFH	TBX10	116	O75333
HRYNAYPSEQEKALL	TGIF1	186	Q15583
AASYHRKKLEEYNAP	TRIM61	136	Q5EBN2
KAFSEAHYPDVYARE	VSX1	181	Q9NZR4
DHPRIVKLYDYFSLD	TLK1	516	Q9UKI8
VYNLCSERAYDPKHF	TPTE	281	P56180
KDFEEYPEHRTNFFL	XPO1	836	O14980
AFLHYYDPSKEENRP	PLEK2	276	Q9NYT0
YEKAYSLQRPNDHEF	SMAD7	371	O15105
EFHEEPKTYYELKSQ	MITF	16	O75030
FAAYLEREYKVHINP	PYGM	546	P11217
LQAVPYDFHAYKEVA	REV1	536	Q9UBZ9
NFYYKHREAVVDGTP	PAPLN	126	O95428
KYYHASLEPVDFVNA	SERPINB13	126	Q9UIV8
DQYTPTIEDFHRKVY	RASD2	46	Q96D21
IDDAYRQGHFTYKPV	SMC6	491	Q96SB8
LDEYYDKHFTEFVPL	ATP6V1A	461	P38606
YTLAQYADALHPEIF	NT5DC2	76	Q9H857
LPKQVADHYDNFRIY	MARS2	456	Q96GW9
KALEVYDEAYRQNPH	TTC21A	746	Q8NDW8
AYRLKFAFADAPNHY	TBC1D22A	501	Q8WUA7
AAYSIAYHSRPLNDF	ZNF862	561	O60290
DSHILDYYENPAIKE	THUMPD3	181	Q9BV44
DYKISQHFPRYLQDL	ZSWIM2	486	Q8NEG5
RVHKSEKSYRPNDYE	ZNF226	216	Q9NYT6
IRTHFEYEKESPYGL	TJP1	521	Q07157
DRFDKYLDPSFFQHR	TM9SF3	206	Q9HD45
HEEFYRYVAQAHDKP	TRAP1	311	Q12931
YFTAVYADEHEKPTL	ZNF462	1806	Q96JM2
KRPANEKATDDYHYE	C9orf78	266	Q9NZ63
ATSLQHLRDYPEKYF	AGPAT4	156	Q9NRZ5
FHVVYVDPRKDSEKY	TBX1	241	O43435
YSFIRDIVNPHAYKN	USP34	2166	Q70CQ2
PEIAHTYKADREKYN	UBE2D4	121	Q9Y2X8
HNQDKFPASYRYSPD	TIGD5	306	Q53EQ6
FDSIPEVVHYYSNEK	SHE	461	Q5VZ18
SEILHHEKQYEPFYS	UBR4	61	Q5T4S7
HEKQYEPFYSSFVAL	UBR4	66	Q5T4S7
PTAKEYFRDLYHRVD	USP7	781	Q93009
DQAYPFLHTKEDTYE	TFR2	591	Q9UP52
NVADHYGVYKPLFEA	ATP6V0D2	266	Q8N8Y2
EYRNRNFYELSPHIF	MYO1B	71	O43795
LTDQHLYKLDPDRQY	MYO1G	891	B0I1T2
SAFHLKQPEEYHYLN	MYO9A	351	B2RTY4
DVFYNTKPYKHRDDR	PCSK1	726	P29120